
Human Fatemi, M.D., Ph.D.
Medical Director of the IVI Middle East
IVI Middle East
Human Fatemi, M.D., Ph.D.
Biography
Prof. Dr. Human M. Fatemi is the Medical Director of the Middle East operations for IVI-ME in Abu Dhabi/Dubai/Muscat since 2014. He completed medical school as Magna Cum Laude in 1999 at the Vrije Universiteit Brussel, in Belgium. In 2008, he completed his Ph.D. on the endocrinology of the luteal phase in stimulated and substituted cycles. Also in 2008, he was recognized as a subspecialist in Reproductive Medicine and Surgery by ESHRE (European society of Human Reproduction) and EBCOG (European Board and College of Obstetrics and Gynecology).
Read more
Education and Training
M.D. “Magnum cum laude” | Free University of Brussels (1999) |
Specialist in Gynecology, Obstetrics and Andrology | University Hospital Brussels/Belgium (2004) |
Clinical Consultant in Reproductive Medicine | University of Brussels (2004-2008) |
Subspecialist in Reproductive Surgery and Medicine by EBCOG and ESHRE | 2008 |
Ph.D. Medical Sciences | University of Brussels (2008) |
Honors and recognition
Visiting Professor of Medical Sciences in Teheran/Iran | 2017-present |
Merck Research Grant | 2017 |
MSD Research Grant | 2012 |
Visiting Professor in Health Sciences at Dubrovnik | 2011 |
Appointed Clinical Professor with a record of excellence, University of Brussels/Belgium | 2009-2014 |
Organon NV Research Grant | 2008 |
Pfizer Educational Grant Award as best graduate fellow in gynecology in Brussels, Belgium | 2005 |
Publications
-
Intracytoplasmic sperm injection is not superior to conventional IVF in couples with non-male factor infertility and preimplantation genetic testing for aneuploidies (PGT-A)
De Munck D El Khatib I Abdala A El-Damen A Bayram A Arnanz A Melado L Lawrenz B Fatemi HM
Hum Reprod. 2020 Feb 29;35(2):317-327. doi: 10.1093/humrep/deaa002. -
The search must go on-for patients with recurrent pregnancy loss
Fatemi HM Lawrenz B
Fertil Steril 2020 -
The ART of frozen embryo transfer: back to nature!
Lawrenz B Coughlan C Melado L Fatemi HM
Gynecol Endocrinol. 2020 Mar 18:1-5. doi: 10.1080/09513590.2020.1740918. [Epub ahead of print] -
Anti-Müllerian hormone is an independent marker for oocyte survival after vitrification
Melado L Arnanz A Bayram A Elkhatib I De Munck N Navarro AT Coughlan C Lawrenz B Fatemi HM
Reprod Biomed Online. 2020 Jul;41(1):119-127. doi: 10.1016/j.rbmo.2020.03.014. Epub 2020 Apr 28. -
Inhibin A-A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI.
Lawrenz B Depret Bixio L Coughlan C Andersen CY Melado L Kalra B Savjani G Fatemi HM Kumar A
Front Endocrinol (Lausanne). 2020 May 15;11:307. doi: 10.3389/fendo.2020.00307. eCollection 2020. -
Is a naturally reduced antimüllerian hormone at a young age linked to an increased risk of cancer development?
Fatemi HM Lawrenz B
Fertil Steril. 2020 Jun;113(6):1161-1162. doi: 10.1016/j.fertnstert.2020.02.105. Epub 2020 May 6. -
Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: a sibling oocyte study.
Arnanz A De Munck N Bayram A El-Damen A Abdalla A ElKhatib I Melado L Lawrenz B Fatemi HM
J Assist Reprod Genet. 2020 Jun;37(6):1387-1397. doi: 10.1007/s10815-020-01795-6. Epub 2020 May 6. -
Anti-Müllerian hormone is an independent marker for oocyte survival after vitrification.
Melado L Arnanz A Bayram A Elkhatib I De Munck N Navarro AT Coughlan C Lawrenz B Fatemi HM
Reprod Biomed Online. 2020 Jul;41(1):119-127. doi: 10.1016/j.rbmo.2020.03.014. Epub 2020 Apr 28. -
Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: a sibling oocyte study.
Arnanz A De Munck N Bayram A El-Damen A Abdalla A ElKhatib I Melado L Lawrenz B Fatemi HM
J Assist Reprod Genet. 2020 Jun;37(6):1387-1397. doi: 10.1007/s10815-020-01795-6. Epub 2020 May 6. -
Is a naturally reduced antimüllerian hormone at a young age linked to an increased risk of cancer development?
Fatemi HM Lawrenz B.
Fertil Steril. 2020 Jun;113(6):1161-1162. doi: 10.1016/j.fertnstert.2020.02.105. Epub 2020 May 6.
Read more
Presentations
- Fatemi HM Bilger W Deborah Denis Griesinger G La Marca A Longobardi S Mahony MC Xiaoyan Yin Thomas M D’Hooghe P-155 DOSE ADJUSTMENT OF FOLLICLE-STIMULATING HORMONE (FSH) DURING OVARIAN STIMULATION AS PART OF MEDICALLY-ASSISTED REPRODUCTION IN CLINICAL STUDIES: A SYSTEMATIC REVIEW COVERING 10 YEARS (2007–2017). Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- Abdala A Elkhatib I A?ina Bayram Ana Arnanz Ahmed El-Damen Lawrenz B Fatemi HM De Munck N P-764 IMPACT OF SLIGHT VARIATIONS OF EXTRACELLULAR CULTURE MEDIA pH (PHE) ON EMBRYO QUALITY, EUPLOIDY RATES AND MITOCHONDRIAL DNA (mtDNA).. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
Read more